Browsing Category
Latest Updates
76 posts
India’s Healthcare Landscape 2024: A Booming Market with Challenges and Opportunities
The Indian healthcare and life sciences market is poised for significant growth, reaching an estimated USD 285 billion…
Healthtech in 2023: A Rundown
Here’s a rundown of what happened in healthtech in 2023. From the AI revolution to lowest global funding, we’ve unpacked everything you need to know.
Google launches MedLM generative AI models fine-tuned for healthcare
Since the launch of ChatGPT by OpenAI, generative AI has taken the world by storm. Every industry is…
Things seldom discussed but healthtech founders must know [to survive 2024]
While the internet is filled with rosy predictions, Christina Farr discusses crucial things healthtech founders must know.
Top HealthTech Predictions for 2024
2023 saw healthtech space go through several challenges—funding issues, down rounds, economic turbulence and whatnot. Nonetheless, 2024 is…
Scientists develop AI-powered wearables to monitor drug abuse
Substance use disorder (SUD), or in simple terms, overconsumption of illegal drugs (cocaine, marijuana, etc.), is a significant…
Universal DX raises $70 million, partners with Quest Diagnostics to bring colorectal cancer screening to the US
Universal DX, a Spanish biotech company aiming to make cancer curable with early screening, made two significant announcements…
AstraZeneca launches new healthtech business, Evinova, to provide AI-powered clinical trial solutions
Operating as a separate business unit within AstraZeneca, Evinova will offer AstraZeneca’s tried-and-tested digital clinical trial solutions to other big pharma, biotech and CROs.
Noise launches Health API for enterprises to leverage health data
These days, smartwatches collect a spectrum of health and fitness metrics, from calories burnt to heart rate and…
Unique IDs for doctors: NMC’s recent move to streamline healthcare in India
Soon, doctors in India will receive their unique identification number. Just like Aadhaar, this number will be a…